Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.457-458 identifier

ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.301-302 identifier

EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians, Paris, France, 23 April 2023, vol.58, pp.107

The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.12673-12674 Creative Commons License identifier

Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), United States Of America, 19 - 22 March 2022

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience

48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), United States Of America, 19 - 22 March 2022

İKİNCİ ALLOJENEİK KÖK HÜCRE NAKLİ: GERÇEK YAŞAM VERİSİ

14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 March 2022

THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION

8 45 th International Congress on Leukemia Lymphoma Myeloma, Ankara, Turkey, 21 May 2021, vol.38, no.71, pp.1-81

Treatment Of Thrombocytopenıa After Allogeneıc Stem Cell Transplantatıonwıth Eltrombopag

46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 August - 01 September 2020

CD34 VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134 identifier

Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.382 identifier

Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.505-506 identifier

Is mobilization with chemotherapy effect response in the multiple myeloma?

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.500 identifier

Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37 identifier

CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION

7th International Congress on Leukemia Lymphoma, İstanbul, Turkey, 2 - 04 May 2019

Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2019

Posttransplant Lenfositoz Önemli Bir Parametre midir?

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019

Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

Transplant and Cell Therapy Meeting / Combined Annual Meetings of the American-Society-for-Blood-and-Marrow-Transplantation (ASBMT) and the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR), Texas, United States Of America, 13 - 24 February 2019, vol.25 identifier

İmmun Trombositopeni (İTP) hastalarında ABO kan gruplarının birinci basamak tedavi yanıtına etkisi

TKBD Uluslararası Katılımlı Hematolojik Hastalıkların Tanı Ve İzleminde Laboratuvar Sempozyumu, Turkey, 5 - 07 April 2018, vol.16, pp.44

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132 identifier identifier

Donor lymphocyte infusion after salvage chemotherapy in relapsed acute myeloblastic leukemia patients after allogeneic stem cell transplantation

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.161-162 identifier

Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.272-273 identifier

Is post-transplant albumin a predictor of early transplant complications?

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.344-345 identifier

ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ SONRASIAKUT MYELOİD LÖSEMİ NÜKSÜNÜN YÖNETİMİ VEPROGNOZU

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2018, pp.126-127

Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, United States Of America, 21 - 25 February 2018, vol.24 identifier

AKUT GRAFT VERSUS HOST HASTALIĞI KLİNİK SONUÇLARI: TEK MERKEZ DENEYİMİ

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 01 March 2018

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130 identifier

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130 identifier

Large unstained cell percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France, 26 - 29 March 2017, vol.52, pp.141-142 identifier identifier

Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantations for acute myeloid leukemia.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35 identifier

A single center experience with two decades of follow-up on patients with hairy cell leukemia.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35 identifier

Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34 identifier